Scientists use monkeys to experiment with tradition.

American researchers have developed a new type of AIDS vaccine, and monkey experiments show that vaccination with this vaccine can protect them from virus infection similar to human AIDS virus. This has brought new hope for the prevention and treatment of AIDS.

Researchers from Scripps Institute and other institutions in the United States reported the relevant results in the American academic journal Immunization. They developed this vaccine against the weakness of the protein shell of HIV, which will trigger the immune system to produce an antibody, which can attack the virus-related weaknesses, thus playing a protective role.

The researchers injected some rhesus monkeys with different doses of new vaccines, some of which produced high levels of antibodies, while others produced low levels of antibodies. When faced with the monkey immunodeficiency virus, which is very similar to human HIV, monkeys that produce high levels of antibodies in their bodies can avoid infection. The researchers said that this will help to determine the appropriate dose of this vaccine in the future.

Extended data

The significance of this experiment lies in:

1, adding ideas for AIDS prevention and treatment. Previously, some AIDS vaccines were developed by T cells of the immune system, but this new vaccine relies on the aforementioned antibodies, and its mechanism of action is also different, which adds new ideas for the prevention and treatment of AIDS.

2. It provides a new optional means for AIDS treatment, so that patients do not need to take antiretroviral drugs continuously.

3. The results of this study are also conducive to the development of new and effective AIDS vaccines.

People's Network-A new AIDS vaccine developed by the United States has been proved to be effective in monkey experiments.